Diadenosine tetraphosphate protects sympathetic terminals from 6-hydroxydopamine-induced degeneration in the eye

Acta Physiologica

Volumn 199, Issue 2, 2010, Pages 205-210

  Hoyle, C H V ^a   Pintor, J J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

6 hydroxydopamine; Diadenosine tetraphosphate; Eye; Neurodegeneration; P2Y receptors; Sympathetic nervous system

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; BIOLOGICAL MARKER; DIADENOSINE PENTAPHOSPHATE; DIADENOSINE TETRAPHOSPHATE; OXIDOPAMINE; PURINERGIC P2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VESICLE MONOAMINE TRANSPORTER 2; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTITHROMBOCYTIC AGENT; DINUCLEOSIDE PHOSPHATE; NEUROPROTECTIVE AGENT; VESICULAR MONOAMINE TRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EYE PROTECTION; IMMUNOREACTIVITY; INTRAOCULAR PRESSURE ABNORMALITY; MALE; MIOSIS; NERVE CELL; NERVE DEGENERATION; NERVE ENDING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PUPIL REFLEX; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE; ANIMAL; AQUEOUS HUMOR; CHEMISTRY; DRUG EFFECTS; EYE; HUMAN; LACRIMAL FLUID; METABOLISM; PATHOLOGY; RABBIT; SYMPATHETIC NERVE CELL; SYNAPSE; TOXICITY; ULTRASTRUCTURE;

ADRENERGIC AGENTS; ANIMALS; AQUEOUS HUMOR; DINUCLEOSIDE PHOSPHATES; EYE; HUMANS; MALE; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PLATELET AGGREGATION INHIBITORS; RABBITS; SYMPATHETIC FIBERS, POSTGANGLIONIC; SYNAPSES; TEARS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 77951211576     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2010.02089.x     Document Type: Article

References (55)

1. Alarma-Estrany, P., Crooke, A., Peral, A. Pintor, J. 2007. Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT. Auton Neurosci 137, 63 66. (Pubitemid 350101431)
2. Andrew, R., Watson, D.G., Best, S.A., Midgley, J.M., Wenlong, H. Petty, R.K. 1993. The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res 18, 1175 1177. (Pubitemid 23306353)
3. Ashley, N., Harris, D. Poulton, J. 2005. Detection of mitochondrial DNA depletion in living human cells using PicoGreen staining. Exp Cell Res 303, 432 446. (Pubitemid 40126275)
4. Bayer, A.U., Keller, O.N., Ferrari, F. Maag, K.P. 2002. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol 133, 135 137. (Pubitemid 34076513)
5. Bergmanson, J.P. 1982. Neural control of intraocular pressure. Am J Optom Physiol Opt 59, 94 98.
6. Clark, C.V. 1989. Autonomic denervation hypersensitivity in the primary glaucomas. Eye 3 (Pt 3 349 354.
7. Crooke, A., Guzman-Aranguez, A., Peral, A., Abdurrahman, M.K. Pintor, J. 2008. Nucleotides in ocular secretions: their role in ocular physiology. Pharmacol Ther 119, 55 73.
8. Curtius, H.C., Wolfensberger, M., Steinmann, B., Redweik, U. Siegfried, J. 1974. Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus. J Chromatogr 99, 529 540.
9. Dabbeni-Sala, F., Di Santo, S., Franceschini, D., Skaper, S.D. Giusti, P. 2001. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J 15, 164 170. (Pubitemid 32061667)
10. Farahbakhsh, N.A. Cilluffo, M.C. 2002. P2 purinergic receptor-coupled signaling in the rabbit ciliary body epithelium. Invest Ophthalmol Vis Sci 43, 2317 2325.
11. Frohlich, R., Boehm, S. Illes, P. 1996. Pharmacological characterization of P2 purinoceptor types in rat locus coeruleus neurons. Eur J Pharmacol 315, 255 261. (Pubitemid 26414270)
12. Ginsberg, S.P., Polack, F.M., Ravin, M.B. Smith, M.D. 1972. Autonomic dysfunction syndrome. Am J Ophthalmol 74, 1121 1125.
13. Giraldez, L., Diaz-Hernandez, M., Gomez-Villafuertes, R., Pintor, J., Castro, E. Miras-Portugal, M.T. 2001. Adenosine triphosphate and diadenosine pentaphosphate induce [Ca(2+)](i) increase in rat basal ganglia aminergic terminals. J Neurosci Res 64, 174 182.
14. Glinka, Y., Gassen, M. Youdim, M.B. 1997. Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm Suppl 50, 55 66. (Pubitemid 27055928)
15. Goldstein, D.S., Robertson, D., Esler, M., Straus, S.E. Eisenhofer, G. 2002. Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med 137, 753 763. (Pubitemid 35265320)
16. Guzman-Aranguez, A., Crooke, A., Peral, A., Hoyle, C.H. Pintor, J. 2007. Dinucleoside polyphosphates in the eye: from physiology to therapeutics. Prog Retin Eye Res 26, 674 687. (Pubitemid 47628845)
17. Harrison, M.J. Brossmer, R. 1975. Inhibition of platelet aggregation and the platelet release reaction by alpha, omega diadenosine polyphosphates. FEBS Lett 54, 57 60.
18. Harvey, B.K., Chou, J., Shen, H., Hoffer, B.J. Wang, Y. 2009. Diadenosine tetraphosphate reduces toxicity caused by high-dose methamphetamine administration. Neurotoxicology 30, 436 444.
19. Hoyle, C.H. 1990. Pharmacological activity of adenine dinucleotides in the periphery: possible receptor classes and transmitter function. Gen Pharmacol 21, 827 831.
20. Hoyle, C.H., Knight, G.E. Burnstock, G. 1990. Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br J Pharmacol 99, 617 621. (Pubitemid 20069174)
21. Hoyle, C.H.V., Hilderman, R.H., Pintor, J.J., Schlüter, H. King, B.F. 2001. Diadenosine polyphosphates as extracellular signal molecules. Drug Dev Res 52, 260 273. (Pubitemid 32401948)
22. Javitch, J.A., D'Amato, R.J., Strittmatter, S.M. Snyder, S.H. 1985. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82, 2173 2177.
23. Jellinger, K., Linert, L., Kienzl, E., Herlinger, E. Youdim, M.B. 1995. Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease. J Neural Transm Suppl 46, 297 314. (Pubitemid 26043238)
24. Klishin, A., Lozovaya, N., Pintor, J., Miras-Portugal, M.T. Krishtal, O. 1994. Possible functional role of diadenosine polyphosphates: negative feedback for excitation in hippocampus. Neuroscience 58, 235 236. (Pubitemid 24037234)
25. Kumar, R. Ahuja, V.M. 1999. A study of changes in the status of autonomic nervous system in primary open angle glaucoma cases. Indian J Med Sci 53, 529 534.
26. Louie, S., Kim, B.K. Zamecnik, P. 1988. Diadenosine 5′, 5′′-P1,P4-tetraphosphate, a potential antithrombotic agent. Thromb Res 49, 557 565.
27. Manzini, S., Hoyle, C.H. Burnstock, G. 1986. An electrophysiological analysis of the effect of reactive blue 2, a putative P2-purinoceptor antagonist, on inhibitory junction potentials of rat caecum. Eur J Pharmacol 127, 197 204. (Pubitemid 16030436)
28. Mediero, A., Guzman-Aranguez, A., Crooke, A., Peral, A. Pintor, J. 2008. Corneal re-epithelialization stimulated by diadenosine polyphosphates recruits RhoA/ROCK and ERK1/2 pathways. Invest Ophthalmol Vis Sci 49, 4982 4992.
29. Miras-Portugal, M.T., Gualix, J. Pintor, J. 1998. The neurotransmitter role of diadenosine polyphosphates. FEBS Lett 430, 78 82. (Pubitemid 28307035)
30. Mitchell, C.H., Carre, D.A., McGlinn, A.M., Stone, R.A. Civan, M.M. 1998. A release mechanism for stored ATP in ocular ciliary epithelial cells. Proc Natl Acad Sci USA 95, 7174 7178.
31. Oaknin, S., Rodriguez-Ferrer, C.R., Aguilar, J.S., Ramos, A. Rotllan, P. 2001. Receptor binding properties of di (1,N6-ethenoadenosine) 5′, 5′′-P1, P4-tetraphosphate and its modulatory effect on extracellular glutamate levels in rat striatum. Neurosci Lett 309, 177 180. (Pubitemid 32763168)
32. Patel, K., Barnes, A., Camacho, J., Paterson, C., Boughtflower, R., Cousens, D. Marshall, F. 2001. Activity of diadenosine polyphosphates at P2Y receptors stably expressed in 1321N1 cells. Eur J Pharmacol 430, 203 210. (Pubitemid 33050039)
33. Peral, A., Gallar, J. Pintor, J. 2009. Adenine nucleotide effect on intraocular pressure: involvement of the parasympathetic nervous system. Exp Eye Res 89, 63 70.
34. Pintor, J. 2005. Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucoma. Curr Opin Investig Drugs 2000, 6.
35. Pintor, J., Diaz-Rey, M.A., Torres, M. Miras-Portugal, M.T. 1992. Presence of diadenosine polyphosphates - Ap4A and Ap5A - in rat brain synaptic terminals. Ca2+ dependent release evoked by 4-aminopyridine and veratridine. Neurosci Lett 136, 141 144.
36. Pintor, J., Porras, A., Mora, F. Miras-Portugal, M.T. 1993. Amphetamine-induced release of diadenosine polyphosphates - Ap4A and Ap5A - from caudate putamen of conscious rat. Neurosci Lett 150, 13 16. (Pubitemid 23142314)
37. Pintor, J., Porras, A., Mora, F. Miras-Portugal, M.T. 1995. Dopamine receptor blockade inhibits the amphetamine-induced release of diadenosine polyphosphates, diadenosine tetraphosphate and diadenosine pentaphosphate, from neostriatum of the conscious rat. J Neurochem 64, 670 676.
38. Pintor, J., Carracedo, G., Alonso, M.C., Bautista, A. Peral, A. 2002. Presence of diadenosine polyphosphates in human tears. Pflugers Arch 443, 432 436. (Pubitemid 34098533)
39. Pintor, J., Peral, A., Pelaez, T., Martin, S. Hoyle, C.H. 2003. Presence of diadenosine polyphosphates in the aqueous humor: their effect on intraocular pressure. J Pharmacol Exp Ther 304, 342 348. (Pubitemid 36008947)
40. Ross, F.M., Brodie, M.J. Stone, T.W. 1999. Nucleotide and dinucleotide effects on rates of paroxysmal depolarising bursts in rat hippocampus. Prog Brain Res 120, 251 262.
41. Ryu, J.K., Kim, J., Choi, S.H., Oh, Y.J., Lee, Y.B., Kim, S.U. Jin, B.K. 2002. ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors. Neuroreport 13, 1611 1615.
42. Sachs, C. Jonsson, G. 1975. Mechanisms of action of 6-hydroxydopamine. Biochem Pharmacol 24, 1 8.
43. Schachter, J.B., Li, Q., Boyer, J.L., Nicholas, R.A. Harden, T.K. 1996. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br J Pharmacol 118, 167 173. (Pubitemid 26135143)
44. Sen, R.P., Delicado, E.G., Castro, E. Miras-Portugal, M.T. 1993. Effect of P2Y agonists on adenosine transport in cultured chromaffin cells. J Neurochem 60, 613 619. (Pubitemid 23030958)
45. al-Sereiti, M.R., Turner, P. Gale, E.A. 1991. Intraocular pressure and pupillary responses in patients with diabetes mellitus. Postgrad Med J 67, 250 251.
46. Soto, D., Pintor, J., Peral, A., Gual, A. Gasull, X. 2005. Effects of dinucleoside polyphosphates on trabecular meshwork cells and aqueous humor outflow facility. J Pharmacol Exp Ther 314, 1042 1051. (Pubitemid 41205967)
47. Vigne, P., Breittmayer, J.P. Frelin, C. 2000. Diadenosine polyphosphates as antagonists of the endogenous P2Y(1) receptor in rat brain capillary endothelial cells of the B7 and B10 clones. Br J Pharmacol 129, 1506 1512. (Pubitemid 30175725)
48. Von Kügelgen, I. 2008. Pharmacology of mammalian P2X- and P2Y-receptors. Biotrend Rev 3, 1 11.
49. Vroegop, S.M., Decker, D.E. Buxser, S.E. 1995. Localization of damage induced by reactive oxygen species in cultured cells. Free Radic Biol Med 18, 141 151.
50. Wang, Y., Chang, C.F., Morales, M., Chiang, Y.H., Harvey, B.K., Su, T.P., Tsao, L.I., Chen, S. Thiemermann, C. 2003. Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain. J Neurosci 23, 7958 7965. (Pubitemid 37052365)
51. Windscheif, U., Pfaff, O., Ziganshin, A.U., Hoyle, C.H., Baumert, H.G., Mutschler, E., Burnstock, G. Lambrecht, G. 1995. Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical field stimulation in guinea-pig taenia coli and rat duodenum. Br J Pharmacol 115, 1509 1517.
52. Xie, Z. Miller, G.M. 2009. A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain. J Pharmacol Exp Ther 330, 316 325.
53. Yenice, O., Onal, S., Midi, I., Ozcan, E., Temel, A. D, I.G. 2008. Visual field analysis in patients with Parkinson's disease. Parkinsonism Relat Disord 14, 193 198. (Pubitemid 351458421)
54. Ziganshin, A.U., Hoyle, C.H., Bo, X., Lambrecht, G., Mutschler, E., Baumert, H.G. Burnstock, G. 1993. PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder. Br J Pharmacol 110, 1491 1495. (Pubitemid 23360983)
55. Zmijewski, M.A., Sweatman, T.W. Slominski, A.T. 2009. The melatonin-producing system is fully functional in retinal pigment epithelium (ARPE-19). Mol Cell Endocrinol 307, 211 216.